In July 2024 , Genentech , a member of the Roche Group announced positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity
I know the argument is that it normalizes acne, but to me it just looks childish and distracting, lik WORTH it #ratemyempties #lemon8challenge #pimplepatch #mightypatch #pimples These are my fav pimple patches
2024 Apr 25;16(9):1271
This isn't dangerous in normal life, but it does mean: Your fat metabolism may be running at a sub-optimal level Supplementation has a bigger relative impact for you than for a meat-eater Even 1000mg daily can produce noticeable improvements in energy levels and fat utilisation Recommendation for vegetarians: Don't underestimate 1000mg
Data source: the KFF Health Tracking Poll, fielded October 27 to November 2, 2025 among 1,350 U.S